|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 117.40 PLN | -0.68% |
|
-0.67% | -13.36% |
| 05-27 | Scope Fluidics says Bacteromic granted U.S. patent 'microfluidic chip' | RE |
| 05-15 | Scope Fluidics Q1 net loss at 13.5 million zlotys | RE |
Evolution of the Average Target: Scope Fluidics S.A.
Evolution of the Target Price: Scope Fluidics S.A.
Changes in Analyst Recommendations: Scope Fluidics S.A.
d7de206f3bc10e7.7oDji_mbNo3vKbKq1HEuLmtIsYLagLGyIjKcpM4nags.3PiswZvYY8iBH4f8rh5JbB0Q37Ho09nBbnXu96xFMDuo0oLKntAB_aB-5w~19bf1135364f6c078d1066fcc0ca5952
| Consensus | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Objective/dr gap | ||
|---|---|---|---|---|---|---|
| - | - | +67.68% | ||||
| +1.68% | ||||||
| -1.13% | ||||||
| +79.59% | ||||||
| - | - | +28.32% | ||||
| -2.64% | ||||||
| -11.81% | ||||||
| - | +57.8% | |||||
| Average | +27.44% | |||||
| Weighted average by Cap. | +17.19% |
Analysts' Consensus
Sell
Buy

Mean consensus
BUY
Number of Analysts
1
Last Close Price
118.20PLN
Average target price
198.20PLN
Spread / Average Target
+67.68%
High Price Target
198.20PLN
Spread / Highest target
+67.68%
Low Price Target
198.20PLN
Spread / Lowest Target
+67.68%
Analyst Consensus Detail
Consensus revision (last 18 months)
Sell
Buy

Mean consensus
BUY
Number of Analysts
1
Last Close Price
118.20PLN
Average target price
198.20PLN
Spread / Average Target
+67.68%
Annual profits - Rate of surprise
- Stock Market
- Stocks
- SCP Stock
- Consensus Scope Fluidics S.A.
Select your edition
All financial news and data tailored to specific country editions
















